Tonix Pharmaceuticals Holding (TNXP) Invested Capital (2011 - 2024)
Tonix Pharmaceuticals Holding's (TNXP) quarterly Invested Capital came in at $5.8 million in Q4 2024, down 32.6% year-on-year from $8.6 million in Q1 2024, and down 10.79% quarter-over-quarter from $6.5 million in Q3 2024.
Tonix Pharmaceuticals Holding (TNXP) Invested Capital (2011 - 2024) Analysis & Trends
Tonix Pharmaceuticals Holding's Invested Capital history runs 3 years deep, the most recent figure standing at $5.8 million for Q4 2024.
- On a quarterly basis, Invested Capital fell 32.6% year-over-year to $5.8 million in Q4 2024; TTM through Sep 2025 was $5.8 million, a 80.8% decrease from a year earlier, with the FY2024 full-year figure at $5.8 million, down 32.6% from the prior year.
- Invested Capital declined to $5.8 million in Q4 2024 per TNXP's latest filing, from $6.5 million in the prior quarter.
- Across five years, Invested Capital topped out at $8.6 million in Q4 2023 and bottomed at $5.8 million in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Invested Cap. (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | 110.96 Mn |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 116.14 Mn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | - |
| 10 | Tonix Pharmaceuticals Holding | 142.07 Mn | 142.07 Mn | 5.30 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 5.83 Mn |
| Sep 30, 2024 | 6.54 Mn |
| Jun 30, 2024 | 7.24 Mn |
| Mar 31, 2024 | 7.95 Mn |
| Dec 31, 2023 | 8.65 Mn |
| Dec 31, 2011 | 150,000.00 |
| Sep 30, 2011 | 10,000.00 |